Clinical trials / NCT05023018
NCT05023018Phase 2Recruiting

NEO100 and High-Grade Meningioma

Study sponsor: Neonc Technologies, Inc.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov recordCSV export · Pro
Primary completion2026-12-30Estimated
Enrollment · participants30Estimated
Source updated2026-09-15Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 1 field changed

Primary completion date changed

− Before

30 Sep 2025

+ After

30 Dec 2026

Check registry source